Eurofins Discovery supports COVID-19 research

By The Science Advisory Board staff writers

Eurofins Discovery has announced that it aims to accelerate COVID-19 antiviral drug discovery research.

Researchers are exploring treatment strategies for the disease that include targeting angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), and the SARS-CoV-2 main protease, as well as large molecule therapies, the company said.

Eurofins Discovery offers these researchers the following services:

  • Bioassays and target specific assays
  • Custom assay development
  • Cytokine storm assessment
  • Drug repositioning services
  • Efficacy testing
  • Safety profiling

Copyright © 2020

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking